179 related articles for article (PubMed ID: 19675197)
1. Diabetic retinopathy is associated with elevated serum asymmetric and symmetric dimethylarginines.
Abhary S; Kasmeridis N; Burdon KP; Kuot A; Whiting MJ; Yew WP; Petrovsky N; Craig JE
Diabetes Care; 2009 Nov; 32(11):2084-6. PubMed ID: 19675197
[TBL] [Abstract][Full Text] [Related]
2. ADMA, SDMA and L-arginine/ADMA ratio but not DDAH genetic polymorphisms are reliable predictors of diabetic nephropathy progression as identified by competing risk analysis.
Tanhäuserová V; Tomandl J; Pácal L; Klepárník M; Malúšková D; Bartáková V; Kuricová K; Rehořová J; Stěpánková S; Svojanovský J; Olšovský J; Bělobrádková J; Krusová D; Jurajda M; Mužík J; Pavlík T; Kaňková K
Kidney Blood Press Res; 2012; 36(1):200-8. PubMed ID: 23147199
[TBL] [Abstract][Full Text] [Related]
3. Levels of asymmetric dimethylarginine in plasma and aqueous humor: a key risk factor for the severity of fibrovascular proliferation in proliferative diabetic retinopathy.
Guo X; Jin W; Xing Y
Front Endocrinol (Lausanne); 2024; 15():1364609. PubMed ID: 38933824
[TBL] [Abstract][Full Text] [Related]
4. Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes.
Tarnow L; Hovind P; Teerlink T; Stehouwer CD; Parving HH
Diabetes Care; 2004 Mar; 27(3):765-9. PubMed ID: 14988299
[TBL] [Abstract][Full Text] [Related]
5. Admission levels of asymmetric and symmetric dimethylarginine predict long-term outcome in patients with community-acquired pneumonia.
Vögeli A; Ottiger M; Meier MA; Steuer C; Bernasconi L; Kulkarni P; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Respir Res; 2017 Jan; 18(1):25. PubMed ID: 28114935
[TBL] [Abstract][Full Text] [Related]
6. Plasma asymmetric dimethylarginine (ADMA) is associated with retinopathy in type 2 diabetes.
Malecki MT; Undas A; Cyganek K; Mirkiewicz-Sieradzka B; Wolkow P; Osmenda G; Walus-Miarka M; Guzik TJ; Sieradzki J
Diabetes Care; 2007 Nov; 30(11):2899-901. PubMed ID: 17704346
[No Abstract] [Full Text] [Related]
7. Cross Talk between Lipid Metabolism and Inflammatory Markers in Patients with Diabetic Retinopathy.
Crosby-Nwaobi R; Chatziralli I; Sergentanis T; Dew T; Forbes A; Sivaprasad S
J Diabetes Res; 2015; 2015():191382. PubMed ID: 26295054
[TBL] [Abstract][Full Text] [Related]
8. Asymmetric and Symmetric Dimethylarginines are Markers of Delayed Cerebral Ischemia and Neurological Outcome in Patients with Subarachnoid Hemorrhage.
Appel D; Seeberger M; Schwedhelm E; Czorlich P; Goetz AE; Böger RH; Hannemann J
Neurocrit Care; 2018 Aug; 29(1):84-93. PubMed ID: 29560598
[TBL] [Abstract][Full Text] [Related]
9. Serum L-arginine and dimethylarginine levels in migraine patients with brain white matter lesions.
Erdélyi-Bótor S; Komáromy H; Kamson DO; Kovács N; Perlaki G; Orsi G; Molnár T; Illes Z; Nagy L; Kéki S; Deli G; Bosnyák E; Trauninger A; Pfund Z
Cephalalgia; 2017 May; 37(6):571-580. PubMed ID: 27206959
[TBL] [Abstract][Full Text] [Related]
10. Plasma Arginine and Citrulline are Elevated in Diabetic Retinopathy.
Peters KS; Rivera E; Warden C; Harlow PA; Mitchell SL; Calcutt MW; Samuels DC; Brantley MA
Am J Ophthalmol; 2022 Mar; 235():154-162. PubMed ID: 34587493
[TBL] [Abstract][Full Text] [Related]
11. Elevation of serum asymmetrical and symmetrical dimethylarginine in patients with advanced glaucoma.
Javadiyan S; Burdon KP; Whiting MJ; Abhary S; Straga T; Hewitt AW; Mills RA; Craig JE
Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):1923-7. PubMed ID: 22395885
[TBL] [Abstract][Full Text] [Related]
12. Asymmetric Dimethylarginine Predicts Long-Term Outcome in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Vögeli A; Ottiger M; Meier MA; Steuer C; Bernasconi L; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Lung; 2017 Dec; 195(6):717-727. PubMed ID: 28852826
[TBL] [Abstract][Full Text] [Related]
13. Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA).
Tain YL; Hsu CN
Toxins (Basel); 2017 Mar; 9(3):. PubMed ID: 28272322
[TBL] [Abstract][Full Text] [Related]
14. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes.
Tsikas D; Bollenbach A; Hanff E; Kayacelebi AA
Cardiovasc Diabetol; 2018 Jan; 17(1):1. PubMed ID: 29301528
[TBL] [Abstract][Full Text] [Related]
15. Increased Serum Levels of Asymmetric Dimethylarginine and Symmetric Dimethylarginine and Decreased Levels of Arginine in Sudanese Patients with Essential Hypertension.
Gamil S; Erdmann J; Schwedhelm E; Bakheit KH; Abdalrahman IBB; Mohamed AO
Kidney Blood Press Res; 2020; 45(5):727-736. PubMed ID: 32814314
[TBL] [Abstract][Full Text] [Related]
16. Asymmetric dimethylarginine levels in thyroid diseases.
Arikan E; Karadag CH; Guldiken S
J Endocrinol Invest; 2007 Mar; 30(3):186-91. PubMed ID: 17505150
[TBL] [Abstract][Full Text] [Related]
17. Asymmetric and symmetric dimethylarginine are associated with coronary artery lesions in Kawasaki disease.
Huang YH; Tain YL; Lee CP; Kuo HC
J Pediatr; 2014 Aug; 165(2):295-9. PubMed ID: 24874168
[TBL] [Abstract][Full Text] [Related]
18. Plasma concentrations of arginine and asymmetric dimethylarginine do not reflect their intracellular concentrations in peripheral blood mononuclear cells.
Davids M; Teerlink T
Metabolism; 2013 Oct; 62(10):1455-61. PubMed ID: 23890667
[TBL] [Abstract][Full Text] [Related]
19. Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients.
Fleck C; Janz A; Schweitzer F; Karge E; Schwertfeger M; Stein G
Kidney Int Suppl; 2001 Feb; 78():S14-8. PubMed ID: 11168976
[TBL] [Abstract][Full Text] [Related]
20. Plasma apelin and asymmetric dimethylarginine levels in type 2 diabetic patients with diabetic retinopathy.
Yonem A; Duran C; Unal M; Ipcioglu OM; Ozcan O
Diabetes Res Clin Pract; 2009 Jun; 84(3):219-23. PubMed ID: 19344973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
